Posted on 11/11/2021 3:10:00 PM PST by nickcarraway
A Norfolk doctor has filed a lawsuit against Sentara Norfolk General Hospital this week.
This is the latest update in the News 3 investigation: “Norfolk doctor leading charge for controversial COVID-19 treatment.”
In this lawsuit, Doctor Paul Marik , the director of the hospital's critical care unit, says Sentara's ban of its use to treat patients with ivermectin is deadly and against the law.
"I think it's criminal. It's immoral and it's illegal," Marik said. "Can you understand the toll that that takes that I have young patients, young patients in the 30s and 40s, who I had to watch die, while the hospital prevented me from giving them the treatment I thought was in their best interest?"
Ivermectin is an anti-parasitic drug, widely used to treat worms in horses and cows, that has been at the center of controversy over COVID-19 care.
In the 80-page document, Marik said Sentara issued a directive to doctors last month banning the use of including ivermectin to treat COVID-19 patients unless they were part of a clinical trial.
"It was a memo sent throughout the healthcare system that was really directed personally at me to prevent me from prescribing these medications that I, as the treating physician, wanted to use," he said.
He also made a claim in the lawsuit that said Sentara's policy may have led to the deaths of four of his patients who were never given the opportunity to learn of or be treated with potentially life-saving medicines.
"It's the physician who determines what's the best treatment for the patient, not nameless bureaucrats sitting in an office," Marik said. "I had to stand by idly watching [my patients] die because I was not allowed to do what I'm meant to do."
While News 3 could not confirm those claims, the FDA, CDC, and U.S. Surgeon General warn against ivermectin's use for COVID patients. They said there isn't enough data to support how it works against the virus.
Dr. David Boulware is an infectious disease expert guiding a major study about ivermectin funded by the National Institutes of Health. He said, "If ivermectin is highly effective, then everyone should be using it. And the same time if it's really proven not to be effective, and not have any benefit, that people should not be using it and they should really move on to something else."
Marik’s of use of ivermectin was the subject of Jessica Larche’s investigation in September. On Thursday he told reporter Erin Miller that he has never prescribed ivermectin to Sentara patients or non-Sentara patients.
Marik and his international group of doctors point to a list of smaller studies that suggest the drug is safe and effective at treating COVID-19.
Other doctors say there needs to be more data for there to be bigger clinical trials.
There are some big trials underway right now, but early data has not shown promise for Ivermectin.
Here’s a list of local hospitals and their stance on treating COVID patients with Ivermectin:
Riverside Regional - Allowed
Patient First - Allowed
Secours - Suggests not to use
CHKD - Not allowed
Sentara - Not allowed
Chesapeake Regional declined to comment.
Sentara Healthcare sent a statement to News 3 on Thursday about the lawsuit:
"Sentara Healthcare is consistently ranked among the top hospitals in the nation for quality and patient safety, and follows evidence-based protocols to treat COVID-19 as recommended by trusted agencies including the CDC, NIH and FDA. All of these agencies currently do not recommend the use of ivermectin as a treatment for COVID-19 due to a lack of evidence regarding its safety and efficacy. Sentara generates treatment guidelines by engaging multi-disciplinary groups of clinicians to review literature, care standards and provide expert advice. In most situations, physicians are able to deviate from guidelines to individualize care for patients. However, in some scenarios, treatments that may potentially harm patients or that are widely considered to be outside the standard of care may be limited.
To that end, COVID-19 treatment guidelines at Sentara have been consistently communicated to all medical staff throughout the pandemic using usual channels. The most recent guidelines generated by the multi-disciplinary group of clinicians did include, but were not limited to, guidance on the use of ivermectin. All members of the medical staff receive the same guidelines.
Of note, on Tuesday, November 9, prior to when we were informed about Dr. Marik’s lawsuit, the Journal of Intensive Care Medicine’s (JICM) editorial board retracted a recent article that Dr. Marik co-authored on the MATH+ protocol, in which ivermectin is used. Sentara Healthcare felt obligated to reach out to JICM with our concerns about Sentara Norfolk General Hospital data that the authors used to make conclusions, and provide accurate data to the Journal. After thorough review by JICM’s editorial board, the article was retracted. The Journal followed their retraction guidelines and procedures.
Sentara Healthcare is currently studying this lawsuit and offers no further comment on it at this time."
If they really wanted to stop COVID they would allow Drugs with their Fake vaccine , people would pick the Drugs and tell them to stick the Fake vaccine
re: “There are some big trials underway right now, but early data has not shown promise for Ivermectin. “
WHAT do I read here - week after week - MONTH AFTER MONTH?
WHAT is WRONG with these people?
Is it POSSIBLE that I, a mere layman when it comes to medical issues is BETTER informed than the PROFESSIONALS who went to med school?
????????????????????????????????????
And there will be no clinical trial, because Ivermectin doesn't make anyone any money.
Interesting that the article (unless I missed it) did not bother to mention any of Paul Marik M.D. credentials. For those who might care here is a link to a PDF of his C.V.
https://covid19criticalcare.com/wp-content/uploads/2021/01/FLCCC-Alliance-member-CV-Marik.pdf
For starters there is this,
“Professor of Medicine, with Tenure
EVMS Foundation Distinguished Professorship in Internal Medicine
Chief, Division of Pulmonary and Critical Care Medicine
Eastern Virginia Medical School.”
Thank you for adding that important context concerning the brilliant career of Dr. Marik and his outstanding service to medicine. I believe they are scheduled for an emergency hearing before a judge in the Norfolk circuit court next Thursday (11-18-2021).
Some more background information about Dr. Marik quoted from the FLCCC website follows:
Paul MarikDr. Marik has special knowledge and training in a diverse set of medical fields, with specific training in Internal Medicine, Critical Care, Neurocritical Care, Pharmacology, Anesthesia, Nutrition, and Tropical Medicine and Hygiene. Dr. Marik is currently a tenured Professor of Medicine and Chief of the Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School in Norfolk, Virginia. Dr. Marik has written over 500 peer-reviewed journal articles, 80 book chapters and authored four critical care books. He has been cited over 43,000 times in peer-reviewed publications and has an H-index of 77. He has delivered over 350 lectures at international conferences and visiting professorships. He has received numerous teaching awards, including the National Teacher of the Year award by the American College of Physicians in 2017.
He is the 2nd most published critical care physician in the world ever, and is a world renowned expert in the management of sepsis – his contributions to the understanding and management of the hemodynamic, fluid, nutritional, and supportive care practices in sepsis have transformed the care of patients throughout the world. He also led the Society of Critical Care Medicine task force on corticosteroids in sepsis. He has already co-authored 10 papers on many therapeutic aspects of COVID-19.
The article says Ivermectin is an anti-parasitic. It does not mention it is an anti-viral.
The article says Ivermectin is used on horses and cows. It does not mention it is used on people.
No bias or research here.
Oklahoma Doctors Have Tremendous Success in Treating Nursing Home COVID Patients with Ivermectin
NYS has opened up nursing homes. Bet ivermectin is still not in use in NYS residential care settings.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.